Clinical Trial Update: Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection [NA]

View source ↗

Summary

An update on a raltegravir-based antiretroviral therapy trial for resistant HIV-1 infection; the phase and current trial status are not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Peking Union Medical College | Conditions: AIDS/HIV PROBLEM | NA | Status: UNKNOWN